What amount sold does RPT Labworks, Inc. report in Form D filings?

The latest linked filings report $690K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was RPT Labworks, Inc.'s most recent SEC filing?

RPT Labworks, Inc.'s most recent Form D filing was on 2025-11-21.

How many investors does RPT Labworks, Inc. have?

The most recent Form D filing lists 6 investor(s).

What type of securities does RPT Labworks, Inc. offer?

RPT Labworks, Inc.'s SEC Form D filings indicate equity offerings.

RPT Labworks, Inc.

CIK: 0002097608·Biotechnology·OREGON, WI·Corporation·Founded 2024

Reported Sold

$689,966

Total Filings

Identified Offerings

Last Filed

Nov 21, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

Offering filing timeline

Nov 21, 2025Form D — New notice

Reported sold: $689,966 · Target: $3,000,000

Rule 506(b)·6 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$689,966

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Justin Jeffery

Related Person

Appears on 1 filing

Reinier Hernandez

Related Person

Appears on 1 filing

Evan Sengbusch

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Nov 21, 2025	New	$3,000,000	$689,966	6

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

VST Operating Corp.

Biotechnology

Offering target: $2,187,490

Filed May 15, 2026